MOTS-c Research Guide
A 16-amino-acid peptide encoded in the mitochondrial genome. Covers the AMPK, metabolic and exercise research in cells and mice.
What is MOTS-c?
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a 16-amino-acid peptide encoded by a short open reading frame inside the mitochondrial 12S rRNA gene. It was reported in 2015, following the earlier discovery of humanin, another peptide encoded in mitochondrial DNA (Lee et al., 2015).
It belongs to the group of mitochondrial-derived peptides, signaling peptides encoded by the mitochondria’s own genome rather than by nuclear DNA.
Research areas studied
The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.
Mechanism in cells
The primary target organ of MOTS-c appears to be skeletal muscle. In cells, it inhibits the folate cycle and the linked de novo purine synthesis pathway, which leads to AMPK activation (Lee et al., 2015). Under metabolic stress such as glucose restriction, MOTS-c moves to the nucleus in an AMPK-dependent way and regulates a broad range of nuclear genes, including those with antioxidant response elements. It interacted with stress-responsive transcription factors such as NRF2 (Kim et al., 2018).
Animal studies
In mice, MOTS-c administration prevented age-dependent and high-fat-diet-induced insulin resistance, as well as diet-induced obesity (Lee et al., 2015). A 2021 study reported improved physical performance in young (2 months), middle-aged (12 months) and old (22 months) mice, and examined intermittent administration started late in life (Reynolds et al., 2021).
Observations in humans
The 2021 study also reported that exercise increased the body’s own MOTS-c levels in human skeletal muscle and in circulation (Reynolds et al., 2021). This is an observation about the endogenous peptide, not a trial of administered MOTS-c.
Regulatory status and limits of the evidence
FDA’s compounding safety page lists MOTS-c among nominated substances whose nominations were withdrawn and states that it has not identified any human exposure data for drug products containing it. All interventional findings come from animal and cell models.
Storage and handling
Like most research peptides, MOTS-c is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.
When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.
Quality and COA
Where a certificate of analysis has been published for a product, its product page has a View COA link. Certificates come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.
MOTS-c FAQ
Where is MOTS-c encoded?
In mitochondrial DNA, within a short open reading frame of the 12S rRNA gene. That makes it a mitochondrial-derived peptide.
What pathway is MOTS-c linked to?
Published cell studies report that it inhibits the folate cycle and de novo purine synthesis, leading to AMPK activation, and that it can move to the nucleus under metabolic stress.
Has administered MOTS-c been studied in humans?
No controlled human trials were identified. Human data so far describe the body's own MOTS-c levels rising with exercise.
References
- Lee C, Zeng J, Drew BG, et al. (2015). Cell Metab. PubMed 25738459
- Kim KH, Son JM, Benayoun BA, et al. (2018). Cell Metab. PubMed 29983246
- Reynolds JC, Lai RW, Woodhead JST, et al. (2021). Nat Commun. PubMed 33473109
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 28, 2026. fda.gov
For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.